Pathology Laboratory Equipment Market Analysis

Pathology Laboratory Equipment Market Analysis

To get key market trends

  Download Free Sample

The pathology laboratory equipment market by product is categorized into equipment and disposables. The equipment segment is further subdivided into incubators, laminar flow hood, micro manipulation systems, centrifuges, lab air filtration system, scopes, sonicators and homogenizers, autoclaves and sterilizers, spectrophotometer and microarray equipment, and others. The equipment segment garnered USD 21.4 billion revenue size in the year 2022. The equipment segment is a driving force in the market, meeting the demand for advanced equipment driven by rising disease prevalence and the need for accurate diagnostics. Technological advancements, ongoing research, and development, and increasing healthcare expenditure contribute to its growth. The segment's role in improving diagnostic capabilities and enhancing patient care makes it a key driver of market expansion.
 

Based on end-use, the pathology laboratory equipment market is segmented into diagnostic centers, hospitals, and others. The diagnostic centers segment accounted for over 54% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. The diagnostic centers conduct a high volume of diverse diagnostic tests, requiring advanced equipment for accurate and timely results. Their focus on quality, collaboration, and personalized medicine drives the demand for pathology laboratory equipment. Additionally, the adoption of digital solutions in diagnostic centers further fuels the market growth.
 

U.S. pathology laboratory equipment market accounted for USD 12.6 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. The U.S. holds a dominant position in the market, driven by its advanced healthcare infrastructure, strong research and development capabilities, high disease burden, technological advancements, favourable reimbursement policies, and the presence of key market players. The U.S. population is experiencing a growing burden of chronic conditions such as cardiovascular disorders, cancer, diabetes, and chronic respiratory diseases.
 

For instances, according to the Centers for Disease Control and Prevention (CDC), a significant proportion of U.S. citizens, specifically 6 in 10 individuals, live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. These diseases require accurate and efficient diagnostic testing for timely treatment and management. Therefore, the rising prevalence of chronic diseases contributes to the demand for advanced pathology laboratory equipment in the U.S. healthcare system.